These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23687423)

  • 41. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk Factors, Clinical Presentation, and Outcome of
    Ballouz T; Aridi J; Afif C; Irani J; Lakis C; Nasreddine R; Azar E
    Front Cell Infect Microbiol; 2017; 7():156. PubMed ID: 28523249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two cases of necrotizing fasciitis due to Acinetobacter baumannii.
    Charnot-Katsikas A; Dorafshar AH; Aycock JK; David MZ; Weber SG; Frank KM
    J Clin Microbiol; 2009 Jan; 47(1):258-63. PubMed ID: 18923009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: susceptibility and clinical outcome.
    Kim NH; Hwang JH; Song KH; Choe PG; Kim ES; Park SW; Kim HB; Kim NJ; Park WB; Oh MD
    Scand J Infect Dis; 2013 Apr; 45(4):315-9. PubMed ID: 23113680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical characteristics of Acinetobacter bacteremia differ among genomospecies: A hospital-based retrospective comparative analysis of genotypically identified strains.
    Koizumi Y; Sakanashi D; Ohno T; Yamada A; Shiota A; Kato H; Hagihara M; Watanabe H; Asai N; Watarai M; Murotani K; Yamagishi Y; Suematsu H; Mikamo H
    J Microbiol Immunol Infect; 2019 Dec; 52(6):966-972. PubMed ID: 31813733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.
    Cisneros JM; Reyes MJ; Pachón J; Becerril B; Caballero FJ; García-Garmendía JL; Ortiz C; Cobacho AR
    Clin Infect Dis; 1996 Jun; 22(6):1026-32. PubMed ID: 8783704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
    Lee HY; Huang CW; Chen CL; Wang YH; Chang CJ; Chiu CH
    J Microbiol Immunol Infect; 2015 Dec; 48(6):588-96. PubMed ID: 26055692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical characteristics and outcomes of bacteremia caused by Acinetobacter species other than A. baumannii: comparison with A. baumannii bacteremia.
    Choi SH; Choo EJ; Kwak YG; Kim MY; Jun JB; Kim MN; Kim NJ; Jeong JY; Kim YS; Woo JH
    J Infect Chemother; 2006 Dec; 12(6):380-6. PubMed ID: 17235644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
    Ng TM; Teng CB; Lye DC; Apisarnthanarak A
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):49-55. PubMed ID: 24334798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent bacteremia caused by the Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Lai CC; Hsu HL; Tan CK; Tsai HY; Cheng A; Liu CY; Huang YT; Liao CH; Sheng WH; Hsueh PR
    J Clin Microbiol; 2012 Sep; 50(9):2982-6. PubMed ID: 22760035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors and outcomes of imipenem-resistant Acinetobacter bloodstream infection in North-Eastern Malaysia.
    Deris ZZ; Shafei MN; Harun A
    Asian Pac J Trop Biomed; 2011 Aug; 1(4):313-5. PubMed ID: 23569782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postoperative infection caused by Acinetobacter baumannii misdiagnosed as a free-living amoeba species in a humeral head hemiarthroplasty patient: a case report.
    Tang J; Zhu H; Cai L; Tang T; Tang J; Sun Y; Liu M; Dai K; Qiao Z; Yu C
    Infect Dis Poverty; 2018 Mar; 7(1):33. PubMed ID: 29631621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.
    Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM
    Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR)
    Xiong YQ; Li L; Zhou Y; Kraus CN
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31382389
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED.
    Kang CI; Chung DR; Peck KR; Song JH;
    Am J Emerg Med; 2012 Sep; 30(7):1169-75. PubMed ID: 22030178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Case-control analysis of endemic Acinetobacter baumannii bacteremia in the neonatal intensive care unit.
    Hsu JF; Chu SM; Lien R; Chiu CH; Chiang MC; Fu RH; Lee CW; Huang HR; Tsai MH
    Am J Infect Control; 2014 Jan; 42(1):23-7. PubMed ID: 24176602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for carbapenem non-susceptibility and mortality in Acinetobacter baumannii bacteremia in children.
    Punpanich W; Nithitamsakun N; Treeratweeraphong V; Suntarattiwong P
    Int J Infect Dis; 2012 Nov; 16(11):e811-5. PubMed ID: 22898148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.
    Munoz-Price LS; Zembower T; Penugonda S; Schreckenberger P; Lavin MA; Welbel S; Vais D; Baig M; Mohapatra S; Quinn JP; Weinstein RA
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1057-62. PubMed ID: 20715975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.